Tolazamide
Source: Wikipedia, the free encyclopedia.
Chemical compound
Clinical data | |
---|---|
Trade names | Tolinase |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682482 |
License data |
|
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | metabolized in the liver to active metabolites |
Elimination half-life | 7 hours |
Excretion | Renal (85%) and fecal (7%) |
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Tolazamide is an
sulfonylurea
family (ATC A10BB).
Synthesis
para-Toluenesulfonamide is converted to its carbamate with ethyl chloroformate in the presence of a base. Heating that intermediate with 1-amino-azepane leads to the displacement of the ethoxy group and the formation of tolazemide:[1]
Azepane proper would lead to [13078-23-4].
References
- ^ PMID 14056414.
External links
- "Tolazamide". Medline Plus. U.S. National Library of Medicine.
|
|
---|
VGKCsTooltip Voltage-gated potassium channels
Blockers |
|
---|---|
Activators |
|
IRKsTooltip Inwardly rectifying potassium channel
Blockers |
|
---|---|
Activators |
|
Blockers |
|
---|---|
Activators |
K2PsTooltip Tandem pore domain potassium channel
Blockers |
|
---|---|
Activators |
VGSCsTooltip Voltage-gated sodium channels
Blockers |
|
---|---|
Activators |
|
Blockers | |
---|---|
Activators |
Blockers |
---|
CaCCsTooltip Calcium-activated chloride channel
Blockers |
|
---|---|
Activators |
Blockers | |
---|---|
Activators |
Blockers |
---|
TRPs Tooltip Transient receptor potential channels |
|
---|---|
LGICs Tooltip Ligand gated ion channels |
|
gastrointestinal system is a stub. You can help Wikipedia by expanding it. |